
Vafidemstat
CAS No. 1357362-02-7
Vafidemstat( ORY 2001 | ORY-2001 | ORY2001 | Vafidemstat )
Catalog No. M11465 CAS No. 1357362-02-7
Vafidemstat is a novel potent, selective lysine-specific histone demethylase (LSD1) inhibitor.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 410 | Get Quote |
![]() ![]() |
50MG | 1449 | Get Quote |
![]() ![]() |
100MG | 2196 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameVafidemstat
-
NoteResearch use only, not for human use.
-
Brief DescriptionVafidemstat is a novel potent, selective lysine-specific histone demethylase (LSD1) inhibitor.
-
DescriptionVafidemstat is a novel potent, selective lysine-specific histone demethylase (LSD1) inhibitor.
-
In VitroVafidemstat (ORY-2001), a dual LSD1/MAO-B inhibitor, is a novel epigenetic agent for the treatment of neurodegenerative diseases. LSD1 is a protein that participates in transcription regulation complexes; its modulation can be used to tweak transcriptional imbalances in neurodegenerative disease and redress neuroinflammation and cognitive deficit. Vafidemstat (ORY-2001) can be used in the treatment of Alzheimer's disease.
-
In Vivo——
-
SynonymsORY 2001 | ORY-2001 | ORY2001 | Vafidemstat
-
PathwayChromatin/Epigenetic
-
TargetHistone Demethylase
-
RecptorHistone Demethylase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1357362-02-7
-
Formula Weight336.395
-
Molecular FormulaC19H20N4O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (148.64 mM)
-
SMILES[H][C@@]1([C@@](NCC2=NN=C(N)O2)([H])C1)C(C=C3)=CC=C3OCC4=CC=CC=C4
-
Chemical Name1,3,4-Oxadiazole-2-methanamine, 5-amino-N-[(1R,2S)-2-[4-(phenylmethoxy)phenyl]cyclopropyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
OG-L002
OG-L002 is a novel selective LSD1 inhibitor with IC50 of 20 nM.
-
KDM1A-IN-29
KDM1A-IN-29 is a histone demethylase inhibitor.
-
MRTX-1719
MRTX-1719 is a potent first-in-class selective inhibitor of the PRMT5/MTA complex, with an IC 50 of less than 10 nM in PRMT5/MTA MTAP DEL SDMA cells.